Fresenius medical care annual general meeting: company makes significant progress in its transformation efforts and confirms its ambitious 2024 growth targets

Today's annual general meeting was the first one following the change in legal form completed in november 2023 shareholders voted in favor of the proposed dividend of 1.19 euros, representing an increase of around 6 percent compared to the previous year new compensation system for management board approved ambitious growth targets for 2024 confirmed bad homburg, germany , may 16, 2024 /prnewswire/ -- fresenius medical care (fme), the global leader in providing products and services for people with kidney diseases, is executing its strategic turnaround plan and is well on track to achieve its goals for 2024. at today's annual general meeting, michael sen , chairman of the supervisory board of fresenius medical care ag, said: "fresenius medical care has made significant progress in 2023.
GM Ratings Summary
GM Quant Ranking